Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1148/radiol.2243011372
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saeed, M.
Right arrow Articles by Higgins, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saeed, M.
Right arrow Articles by Higgins, C. B.
(Radiology 2002;224:830-837.)
© RSNA, 2002

Experimental Studies

Left Ventricular Remodeling after Infarction: Sequential MR Imaging with Oral Nicorandil Therapy in Rat Model1

Maythem Saeed, DVM, PhD, Norbert Watzinger, MD, Gabriele A. Krombach, MD, Gunnar K. Lund, MD, Michael F. Wendland, PhD, Mitsuaki Chujo, PhD and Charles B. Higgins, MD

1 From the Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Rm L-308, San Francisco, CA 94143-0628 (M.S., N.W., G.A.K., G.K.L., M.F.W., C.B.H.); and Chugai Pharmaceutical, Tokyo, Japan (M.C.). Received August 13, 2001; revision requested October 9; final revision received March 4, 2002; accepted March 25. Supported by Chugai Pharmaceutical. Address correspondence to M.S. (e-mail: maythem.saeed@radiology.ucsf.edu).

PURPOSE: To use magnetic resonance (MR) imaging in quantification of the short- and long-term effects of therapy with orally administered nicorandil on left ventricular (LV) geometry and function independent of infarction size.

MATERIALS AND METHODS: Forty-six rats were subjected to reperfused infarction and randomly divided into two groups. Group 1 rats (n = 21) were treated with nicorandil (3 mg/kg/day in drinking water) for 4 days before infarction and 8 weeks after infarction (hereafter, the nicorandil group). Group 2 rats (n = 25) received tap water for the same period and served as the control group. Mesoporphyrin- (as a necrosis-specific agent) enhanced MR imaging was used to define necrotic myocardium on day 2 after infarction in all 46 animals. Contrast material–enhanced MR images showed large but identical infarction size in 11 control and 11 nicorandil rats. Only these 22 rats underwent repeat MR imaging at 8 weeks after infarction. The following variables were measured: LV volumes, ejection fraction, mass, wall thickness, and infarction size. Student t test and analysis of variance for repeated measurements were used for statistical analysis.

RESULTS: The size of the necrotic region on mesoporphyrin-enhanced MR images was 39% ± 3 of the size of the left ventricle in the control group and 41% ± 2 in the nicorandil group (difference not significant, unpaired Student t test). Pretreatment with nicorandil for 6 days before imaging did not reduce LV dilation or improve function compared with those in control animals with identical infarction size. Eight weeks after infarction, control animals showed deterioration in LV function, wall thinning, and gradient in regional dysfunction (analysis of variance test). Nicorandil produced significant salutary effects on LV ejection fraction (37% ± 3 in the nicorandil group vs 24% ± 3 in the control group), end-diastolic volume (0.53 mL ± 0.03 vs 0.65 mL ± 0.04), end-systolic volume (0.36 mL ± 0.03 vs 0.49 mL ± 0.05), LV wall thickening in remote noninfarcted myocardium (28% ± 2 vs 19% ± 1), and a rim of infarction (16% ± 2 vs 8% ± 1) (P < .05 for all parameters). The increase in LV mass was reduced in the nicorandil group (0.73 g ± 0.03) compared with that in the control group (0.89 g ± 0.04) (P < .05).

CONCLUSION: In animals studied longitudinally, MR imaging demonstrated the deleterious changes in LV geometry and function in the period after infarction and the salutary effects of medical therapy.

© RSNA, 2002

Index terms: Animals • Heart, experimental studies, 511.12143 • Heart, MR, 511.121411, 511.121416, 511.12143 • Myocardium, infarction, 511.771 • Myocardium, ischemia, 511.1939 • Myocardium, MR, 511.121411, 511.121416, 511.12143




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Effect of ATP-Sensitive Potassium Channel Agonists on Ventricular Remodeling in Healed Rat Infarcts
J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1309 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, C.-H. Tsai, C.-L. Huang, and N.-C. Chang
Effects of sulfonylureas on left ventricular mass in type 2 diabetic patients
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H608 - H613.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
J. Liu, C. Long, B. Ji, H. Zhang, and F. Wen
Myocardial protective effects of nicorandil, an opener of potassium channels on senile rat heart
Perfusion, May 1, 2006; 21(3): 179 - 183.
[Abstract] [PDF]

Home page
 RadiologyHome page
G. A. Krombach, C. B. Higgins, M. Chujo, and M. Saeed
Gadomer-enhanced MR Imaging in the Detection of Microvascular Obstruction: Alleviation with Nicorandil Therapy
Radiology, August 1, 2005; 236(2): 510 - 518.
[Abstract] [Full Text] [PDF]